Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy

Sorafenib, a molecular targeted multi-kinase inhibitor, has received considerable interests in recent years due to its significant profiles of efficacy in cancer therapy. However, poor pharmacokinetic properties such as limited water solubility, rapid elimination and metabolism lead to low bioavaila...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fangmin, Fang, Yifan, Chen, Xiang, Deng, Rui, Zhang, Yongjie, Shao, Jingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261086/
https://www.ncbi.nlm.nih.gov/pubmed/34276821
http://dx.doi.org/10.1016/j.ajps.2020.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261086/
https://www.ncbi.nlm.nih.gov/pubmed/34276821
http://dx.doi.org/10.1016/j.ajps.2020.07.003

Ejemplares similares